Pierian, now a part of Velsera, is integrating Arima's gene fusion sequencing technology into its NGS analysis, interpretation, and reporting hub.

Salignostics is based in Jerusalem and offers a number of saliva-based, lateral flow immunoassays.

The agency also cleared instruments and assays for blood gas and acid-base disturbances, antimicrobial susceptibility, and tacrolimus concentrations.

In December, the company was notified that its shares had failed to meet the Nasdaq's minimum bid price listing requirement.

The California startup sells PCR-based tests for respiratory and sexually transmitted diseases and said it will use the funding toward innovation and expanded sales of its products.

The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete test is a laboratory-use assay run on open RT-PCR instruments.

The Swedish molecular diagnostics startup raised the additional money as part of an oversubscription of an earlier €2.5 million seed financing round.

Last week, readers were most interested in Roche's planned launch of its mass spec clinical analyzer in a market that has proven challenging for other vendors.

The firm said several institutional investors had inked definitive agreements for the purchase and sale of 3,846,155 American Depositary Shares.

The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.